1-161629927-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001244753.2(FCGR3B):c.170C>T(p.Ser57Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000191 in 1,518,162 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001244753.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCGR3B | NM_001244753.2 | c.170C>T | p.Ser57Phe | missense_variant | 3/5 | ENST00000650385.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCGR3B | ENST00000650385.1 | c.170C>T | p.Ser57Phe | missense_variant | 3/5 | NM_001244753.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000375 AC: 4AN: 106648Hom.: 1 Cov.: 15
GnomAD3 exomes AF: 0.00000808 AC: 2AN: 247522Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134010
GnomAD4 exome AF: 0.0000177 AC: 25AN: 1411514Hom.: 3 Cov.: 34 AF XY: 0.0000214 AC XY: 15AN XY: 701250
GnomAD4 genome AF: 0.0000375 AC: 4AN: 106648Hom.: 1 Cov.: 15 AF XY: 0.0000197 AC XY: 1AN XY: 50824
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 05, 2024 | The c.170C>T (p.S57F) alteration is located in exon 4 (coding exon 3) of the FCGR3B gene. This alteration results from a C to T substitution at nucleotide position 170, causing the serine (S) at amino acid position 57 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at